Prevention and Control of Snakebite Envenoming
What’s in the news?
- The Government of India has launched a National Action Plan for Prevention and Control of Snakebite Envenoming (NAP-SE) with a vision to reduce snakebite deaths by halve by 2030.
- NAPSE provides a broad framework for states to develop their own action plan for management, prevention and control of snakebites through the ‘One Health’ approach.
- The activities envisaged under human, wildlife, tribal and Animal health components will be undertaken by concerned stakeholders at all levels.
Background:
- Snakebite envenoming is a potentially life-threatening disease following the bite of a venomous snake.
- Venomous snake bites can result in medical issues which can be deadly or lead to permanent impairment if timely and appropriate treatment is not given.
- The majority of snakebite envenomation deaths and catastrophic sequelae can be avoided with prompt availability to safe and effective antivenoms, timely transport and referral.
- In India, around 50,000 deaths occur of an estimated 3-4 million snakebites annually which accounts for half of all snakebite deaths globally. Only a small proportion of snake bite victims across countries report to the clinics and hospitals and actual burden of snake bite is grossly underreported.
- In India, around 90% of snakebites are caused by the ‘big four’ among the crawlers – common krait, Indian cobra, Russell’s viper and saw scaled viper.
- Administration of polyvalent anti-snake venom (ASV) containing antibodies against cobra, Russell’s viper, common krait and saw scaled viper is effective in 80% of the snakebite cases, however, lack of trained human resources and health facilities to treat snakebite patients remains a cause of concern.
- Also, the unavailability of data on incidence, morbidity, mortality, socio-economic burden, treatment patterns etc. are the major hindrances in planning for mitigation of snakebite in India.
Subscribe
Login
0 Comments